Head-to-head · WeighScore
AquaVita NextGen vs Arc-1
The verdict
Too close to call — both grade 56.3/100 (C).
AquaVita NextGen and Arc-1 land on the same WeighScore, so neither clears the other on our six graded dimensions. AquaVita NextGen sits one line higher on the board (#415 vs #416) on the underlying tiebreak, but it's a genuine coin-flip — pick on the factors and prices that matter most to you below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | AquaVita NextGen | Arc-1 |
|---|---|---|
| WeighScore | 56.3/100 | 56.3/100 |
| Grade | C | C |
| Scorecard rank | #415 | #416 |
| Semaglutide | $375/mo (first-month rate, compounded) | $200/mo (0.5 mg dose, compounded) |
| Tirzepatide | $320/mo (starting dose, 3-month plan, compounded) | $200/mo (2.5 mg dose, compounded) |
| Coverage | 5 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #415 · C
Strengths
- Physical address in Lake Forest CA
- Named medical director (Dr. Steve Groke)
- Both semaglutide and tirzepatide including ODT tablets
- Compounding disclaimer present on site
Where it loses points
- Only 5 states (AZ, CA, FL, TX, NV)
- No LegitScript or PCAB accreditation
- Primarily a local medspa expanding into telehealth
- Only a first-month semaglutide price ($375, originally $499) is published; ongoing monthly price and all tirzepatide pricing remain unpublished
Graded #416 · C
Strengths
- Both compounded semaglutide and tirzepatide available
- Per-dose purchasing — no subscription or membership required
- 25% off plus free shipping promotion
- Broader longevity formulary (rapamycin, NAD+, sermorelin)
- LegitScript Certified badge now displayed on product pages
Where it loses points
- No legal entity name or address disclosed
- State availability not disclosed
- No named clinicians or pharmacy partners
- Per-dose pricing still climbs with dose (semaglutide 2.5mg is $549.99/mo, tirzepatide 7.5mg $399.99/mo)
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.